Moderna 1


eAwaz Medicine

NEW YORK – The nonprofit scientific research organization IAVI and Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant screenings are soon to start for a Phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) at the Center for Family Health Research (CFHR) in Kigali, Rwanda, and The Aurum …

Pfizer and BioNTech

Pfizer-BioNTech Covid Vax Shows Strong Immune Response in Children Under 5

eAwaz Medicine

MAINZ — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age. Following a third dose in this age group, the vaccine was found to elicit a strong immune response, with …

Toronto vaccination clinic

Extending work of Covid Vaccine Engagement Teams 

eAwaz Medicine

Toronto – Mayor John Tory announced that the City of Toronto is extending the work of its COVID-19 Vaccine Engagement Teams (VETs) to December 2022, ensuring continued opportunities to increase vaccine equity and access for all residents. The teams operate through 17 geographic and population-based consortiums made up of over 200 health, community and faith-based organizations, including over 600 community …

vaccination clinic

34 Covid-19 vax clinics across this Victoria Day long weekend

eAwaz Medicine

Toronto – This Victoria Day long weekend, Team Toronto is working to help residents stay up to date with their COVID-19 vaccinations by hosting 34 immunization clinics across the city. The clinics are part of Team Toronto’s ongoing hyper-local approach to bringing COVID-19 vaccination opportunities to the places residents live, work and play. This long weekend’s vaccine clinics will operate …

Peripheral Artery Disease

J& J on Amputation Related to Peripheral Artery Disease

eAwaz Medicine

TITUSVILLE – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives. Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted …

breast cancer

Detecting breast cancer with magnetic marker liquid

eAwaz Medicine

London – Those who have breast cancer in the UK will now be injected with a magnetic marker liquid to help surgeons discover if the cancer has spread or not, say government’s health advisers. Jeanette Kusel, acting director for MedTech and digital at NICE, in a statement: “People with breast cancer want to know if their cancer has been isolated …

albuterol budesonide

PT027, novel fixed-dose combination of albuterol-budesonide

eAwaz Medicine

London -Full results from the positive MANDALA Phase III trial showed that PT027 (albuterol/budesonide) at two different strengths of budesonide, an inhaled corticosteroid (ICS), used as an as-needed rescue medicine, demonstrated a statistically significant reduction in the risk of a severe exacerbation versus albuterol rescue in patients with moderate to severe asthma.1,2 PT027 is a potential first-in-class inhaled, fixed-dose combination …

psilocybin treatment scaled

Psilocybin treatment

eAwaz Medicine

Quebec – Health Canada in January this year restored its “Special Access Program” – abolished under former prime minister Stephen Harper in 2013 – allowing health-care experts to request access to restricted drugs that have not yet been authorized for sale in the country. Health Canada says it has received 15 requests for the use of psilocybin or MDMA – …


Ottawa neighbourhoods with highest vax rates

eAwaz Medicine

Ottawa – Ottawa Neighbourhood Study looks at vaccination rates for two doses and three doses in 102 neighbourhoods across the city of Ottawa. The May update looks at the third dose vaccination rates for residents aged 12 and older in neighbourhoods across the city. Ottawa neighbourhoods with third dose COVID-19 vaccination rates above 70 per cent (12 plus)  Island Park …

Pfizers Biosimilar ABRILADA

Pfizer’s Biosimilar ABRILADA Now Available in Canada

eAwaz Medicine

Kirkland – Pfizer is proud to announce that ABRILADA™ (adalimumab), a biosimilar to the reference biologic drug Humira1 (adalimumab), is now available in Canada for the treatment of certain patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease (in people aged 13 and older), ulcerative colitis, plaque psoriasis, uveitis (in adults and children) and hidradenitis suppurativa …